Paper40921925
Tongxinluo alleviates myocardial ischemia-reperfusion injury by inhibiting the pyroptosis of endothelial cells via the NLRP3/Caspase-1/GSDMD signaling pathway.
Wu X and 6 others. J Mol Histol, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Tongxinluo alleviates myocardial ischemia-reperfusion injury by inhibiting the pyroptosis of endothelial cells via the NLRP3/Caspase-1/GSDMD signaling pathway. Papers, record 40921925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40921925
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tongxinluo alleviates myocardial ischemia-reperfusion injury by inhibiting the pyroptosis of endothelial cells via the NLRP3/Caspase-1/GSDMD signaling pathway.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pyroptosis | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Signal Transduction | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Caspase 1 | Major topic |
| Endothelial Cells | Major topic |
| Phosphate-Binding Proteins | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Humans | |
| Male | |
| Human Umbilical Vein Endothelial Cells | |
| Disease Models, Animal | |
| Network Pharmacology | |
| Gasdermins |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed | ||
| 2022216 | The Scientific Research Project of the Hebei Provincial Administration of Traditional Chinese Medicine funded this study | PubMed |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29330085 | Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. | Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29330085 | PubMed |
| 2 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 3 | 18936753 | Network pharmacology: the next paradigm in drug discovery. | Nat Chem Biol | 2008 | https://conductscience.org/library/papers/18936753 | PubMed |
| 4 | 35130979 | Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35130979 | PubMed |
| 5 | 21034597 | No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial). | Chin Med J (Engl) | 2010 | https://conductscience.org/library/papers/21034597 | PubMed |
| 6 | 23203875 | TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23203875 | PubMed |
| 7 | 26156871 | TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine. | BMC Complement Altern Med | 2015 | https://conductscience.org/library/papers/26156871 | PubMed |
| 8 | 24792161 | SwissTargetPrediction: a web server for target prediction of bioactive small molecules. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24792161 | PubMed |
| 9 | 29126136 | DrugBank 5.0: a major update to the DrugBank database for 2018. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29126136 | PubMed |
| 10 | 26400175 | PubChem Substance and Compound databases. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26400175 | PubMed |
| 11 | 30371825 | PubChem 2019 update: improved access to chemical data. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371825 | PubMed |
| 12 | 26590256 | STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26590256 | PubMed |
| 13 | 25672441 | Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B‑cell lymphoma/B‑cell lymphoma‑associated X protein pathway. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25672441 | PubMed |
| 14 | 27899610 | MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/27899610 | PubMed |
| 15 | 32404014 | PDB-2-PBv3.0: An updated protein block database. | J Bioinform Comput Biol | 2020 | https://conductscience.org/library/papers/32404014 | PubMed |
| 16 | 30087074 | Network-based drug repositioning: A novel strategy for discovering potential antidepressants and their mode of action. | Eur Neuropsychopharmacol | 2018 | https://conductscience.org/library/papers/30087074 | PubMed |
| 17 | 20689021 | GeneCards Version 3: the human gene integrator. | Database (Oxford) | 2010 | https://conductscience.org/library/papers/20689021 | PubMed |
| 18 | 10728386 | Reperfusion induces myocardial apoptotic cell death. | Cardiovasc Res | 2000 | https://conductscience.org/library/papers/10728386 | PubMed |
| 19 | 38926825 | Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38926825 | PubMed |
| 20 | 27066895 | The intersection of cell death and inflammasome activation. | Cell Mol Life Sci | 2016 | https://conductscience.org/library/papers/27066895 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948070 | Pyroptosis in myocardial ischemia-reperfusion injury: mechanistic pathways and therapeutic prospects. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42948070 | PubMed |
| 42819511 | Neutrophil-mediated myocardial ischemia-reperfusion injury: mechanisms and potential therapeutic targets. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819511 | PubMed |
| 42726179 | Imbalance of the Regulated Cell Death and Autophagic Network: A Core Mechanism Driving Toxicological and Ischemic Myocardial Injury and a Target for Intervention with Traditional Chinese Medicine. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42726179 | PubMed |
| 42351906 | Programmed Cell Death of Endothelial Cells in Ischemic Heart Disease: Mechanism and Potential Cell and Gene Therapeutic Prospects. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42351906 | PubMed |
| 41677628 | Molecular and Cellular Mechanisms of Myocardial Ischemia and Reperfusion Injury: A Narrative Review. | Cells | 2026 | https://conductscience.org/library/papers/41677628 | PubMed |
| 41369269 | Breakthroughs of ultrasound-targeted microbubble destruction in treating myocardial ischemia-reperfusion injury: from angiogenesis regulation to precise inflammation suppression. | Drug Deliv | 2025 | https://conductscience.org/library/papers/41369269 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40921925
GET https://conductscience.org/api/papers/v1/40921925/references?page=2